Abstract：OBJECTIVE To analyze the knowledge, attitude and practice of hospital pharmacists on the safety of patients with anti-tumor drugs discharged from hospitals, explore possible risk factors, and provide reference for targeted guidance and rational medication of tumor patients discharged. METHODS From March 15, 2019 to May 31, 2019, pharmacists at hospitals in 31 provinces (cities) in China conducted a questionnaire survey on the safety of patients with anti-tumor drugs discharged from hospitals. RESULTS The average score of pharmacists′ knowledges of anti-tumor drugs was 46.7, equivalent to 51.8% of the total score. Most pharmacists (74.5%) are aware of the risks of discharge of antineoplastic agents and are willing (93.9%) to provide medication guidance for cancer patients. However, the pharmacists′ guidance for patients with cancer on the discharge was mostly limited to oral presentation (62.1%), and the accessibility of pharmacists to cancer patients after discharge was generally low (55.6%). CONCLUSION Drug safety participants pay insufficient attention to the safety risks of patients with anticancer drugs discharged, and hospital pharmacists′ knowledge reserve of anti-tumor drugs has shortcomings, there is no perfect system of medication education for discharged patients, which are all risk factors threatening the safety of medication for cancer patients after discharge. Serious efforts should be made to find solutions to continuously improve the safety of patients with anticancer drugs discharged from hospitals.
杨玉慧, 许秀丽, 朱珠. 医院药师关于出院带抗肿瘤药安全性的知识、态度及实践研究[J]. 中国药学杂志, 2020, 55(6): 480-485.
YANG Yu-hui, XU Xiu-li, ZHU Zhu. Knowledge, Attitudes, and Practices (KAP) Survey on the Safety of Anti-tumor Drugs in Hospital Discharge among Hospital Pharmacist. Chinese Pharmaceutical Journal, 2020, 55(6): 480-485.
SHENG Y Q, LI Q H, WANG Y, et al. Comprehensive intervention before and after drug use to promote clinical rational use of tumor therapy adjuvant drugs[J]. Pharm Clin Res, 2019, 27(3):237-240.
[2]
CAO M M, CHEN W Q. Epidemiology of cancer in China and the current status of prevention and control[J]. Chin J Clin Oncol(中国肿瘤临床), 2019, 46(3):145-149.
[3]
GLOBOCAN. Population Fact Sheets[EB/OL]. GLOBOCAN, (2019-05) [2019-08-03]. https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf.
[4]
GAO F, TENG F, LIANG H, et al. Postdischarge care guidance needs of cancer patients[J]. Chin J Clin Oncol Rehabil, 2019, 26(4):498-501.
[5]
MA Y Q. Statistics on the discharge of drugs in the department of oncology and the drug education of clinical pharmacists on discharged patients[J]. Mod Med J China(中国现代医药), 2018, 20(3):77-79.
[6]
CPA. The pharmacy professional committee of China pharmaceutical association continues to promote high-risk drug management and risk prevention [EB/OL]. CPA, (2019-07-08) [2019-08-03]. http://www.cpa.org.cn/?do=info&cid=75014.
[7]
HESHMAT R, SALEHI F, QORBANI M, et al. Economic inequality in nutritional knowledge, attitude and practice of Iranian households: the NUTRI-KAP study[J]. Med J Islam Repub Iran, 2016,30(1):426.
[8]
GUO W. Effect of KAP nursing program on postoperative quality of life and gastrointestinal function in patients undergoing colon cancer surgery[J]. Chin General Pract Nur(全科护理), 2019, 17(18):2186-2188.
[9]
FAN Q Q, LI Q Y, ZHU Z, et al. Risk analysis from exploratory survey on knowledge, attitude and practice (KAP) towards medication safety among Beijing residents[J]. Chin J Drug Appl Monitor(中国药物应用与临床), 2018, 15(6):368-371.
[10]
HONGYAN L, XIANGLONG X, DENGYUAN L, et al. Nutrition-related knowledge, attitudes, and practices (KAP) among kindergarten teachers in Chongqing, China: a cross-sectional survey[J]. Inter J Environmental Res Public Health, 2018, 15(4):615.
[11]
CHEN C Y, CHEN P J. Production of emergency kit for chemotherapeutic drug spillover treatment[J]. Global Tradit Chin Med, 2015, 8(S1):138.
[12]
CONNOR T, MCLAUCHLAN R, VANDENBROUCKE J. ISOPP Standards of practice. Safe handling of cytotoxics[J]. J Oncol Pharm Pract, 2007, 13(suppl):1-81.
[13]
WANG H Y, XU R, HUANG J L, et al. New practice upon continuous quality management of antineoplastic agents in hospital[J]. Anti-tumor Pharm, 2019, 9(1):139-142.
2020, Vol. 55 
